| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 683833 | Null | 0.00803384002766641 | 0.049813941 |
| NSC 697730 | Null | 0.00803384002766641 | 0.1211162 |
| NSC 727729 | 1, 1'[Pentane-1,5-diyl)dioxy]bis(11as)-2-fluoro-7-methoxy-1,2,3 ,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one | 0.00803384002766641 | -0.0010687268 |
| NSC 712572 | 1,2 Benzo-8-(1-hydroxy-2-methylamino propane)-3-phenoxazone | 0.00928777138079769 | -0.022626959 |
| NSC 237020 | TA 1067 | 0.0107933723273943 | 0.13737467 |
| NSC 637693 | Ethanedioic acid, mono(4,9-dihydro-4,9-dioxonaphtho[2,3-d]thiazol-2-yl)hydrazide, monoethyl ester | 0.0107933723273943 | -0.20726046 |
| NSC 642321 | Null | 0.0107933723273943 | 0.063351968 |
| NSC 668814 | 1-Oxa-4,7,10,13,16-pentaazacyclononadecane, cyclic peptide derivative | 0.0107933723273943 | 0.13346778 |
| NSC 680827 | Null | 0.0107933723273943 | -0.31008738 |
| NSC 96996 | B 169 | 0.0107933723273943 | -0.029726881 |